Comprehensive 2D and 3D phenotypic characterization of human invasive lobular carcinoma cell lines
N. Tasdemir, E. Bossart, Z. Li, Z. Li, K. M. Levine, B. M. Jacobsen, G. C. Tseng, N. E. Davidson, S. Oesterreich
Abstract
Invasive lobular carcinoma (ILC) is the second most common subtype of breast cancer following invasive ductal carcinoma (IDC) and characterized by the loss of E-cadherin-mediated adherens junctions. Despite displaying unique histological and clinical features, ILC still remains a chronically understudied disease with limited knowledge on the available laboratory research models. To this end, herein we report a comprehensive 2D and 3D phenotypic characterization of four Estrogen Receptor-positive human ILC cell lines - MDA-MB-134, SUM44, MDA-MB-330 and BCK4. Compared to the IDC cell lines MCF7, T47D and MDA-MB-231, ultra-low attachment culture conditions revealed a remarkable anchorage-independence ability that was unique to the ILC cells, a feature not evident in soft agar gels. 3D Collagen I and Matrigel culture indicated a generally loose morphology for the ILC cell lines, which exhibited differing preferences for adhesion to ECM proteins in 2D. Furthermore, ILC cells had limited migration and invasion ability in wound-scratch and transwell assays with the exception of haptotaxis to Collagen I. Transcriptional comparison of the cell lines confirmed the decreased cell proliferation and E-cadherin-mediated intercellular junctions in ILC, while uncovering the induction of novel pathways related to cyclic nucleotide phosphodiesterase activity, ion channels, drug metabolism and alternative cell adhesion molecules such as N-cadherin, some of which were also differentially regulated in ILC versus IDC tumors. Altogether, these studies will serve as an invaluable resource for the breast cancer research community and facilitate further functional discoveries towards understanding ILC, identifying novel drug targets and ultimately improving the outcome of patients with ILC.\n\nAuthors ContributionsConception and design: N. Tasdemir, NE. Davidson, S. Oesterreich\n\nDevelopment of methodology: N. Tasdemir, L. Zhu, GC. Tseng, S. Oesterreich\n\nAcquisition of data (performed experiments, processed data, etc.): N. Tasdemir, E. Bossart, Z. Li, Z. Li\n\nAnalysis and interpretation of data (e.g. biological interpretation, statistical analysis, computational analysis): N. Tasdemir, Z. Li, KM. Levine, NE. Davidson, S. Oesterreich\n\nWriting, review and/or revision of the manuscript: N. Tasdemir, Z. Li, KM. Levine, BM. Jacobson, GC. Tseng, NE. Davidson, S. Oesterreich\n\nStudy supervision: NE. Davidson and S. Oesterreich
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Restoration of E-cadherin Expression Alters Metastatic Organotropism in Invasive Lobular Breast Carcinoma Models
Laura Savariau, Nilgun Tasdemir, … Steffi Oesterreich·bioRxiv·May 18, 2026
- Proteomic and Transcriptomic Profiling Identifies Mediators of Anchorage-Independent Growth and Roles of Inhibitor of Differentiation Proteins in Invasive Lobular Breast Cancer
Nilgun Tasdemir, Kai Ding, … Steffi Oesterreich·bioRxiv·Feb 7, 2019
- WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line model
Ashuvinee Elangovan, Emily A. Bossart, … Steffi Oesterreich·bioRxiv·Sep 15, 2023
- Loss of E-cadherin Induces IGF1R Activation Revealing a Targetable Pathway in Invasive Lobular Breast Carcinoma
A. Elangovan, J. Hooda, … A. V. Lee·bioRxiv·Feb 22, 2022
- Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic opportunities
Osama Shiraz Shah, Fangyuan Chen, … Adrian V. Lee·bioRxiv·Sep 26, 2023
- Identification and Credentialing of Patient Derived Xenograft Models of Invasive Lobular Breast Carcinoma using Multi-omics and Histopathology assessment
Jagmohan Hooda, Jennifer M. Atkinson, … Adrian V. Lee·bioRxiv·Aug 21, 2025